Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
A new market comparison frames Eli Lilly’s stock as trading at a higher earnings multiple tied to growth expectations, while Teva is portrayed as working through debt reduction and expanding in biosimilars.
THE APEX TIMES
THE APEX TIMES
Market coverage is pointing to a potential repeat of Leidos’ recent pattern of beating consensus earnings, citing a two-quarter surprise streak and more favorable estimate expectations ahead of its next report.
THE APEX TIMES
Deutsche Bank raised its Honeywell price target to $263 from $250 and kept a Buy rating, pointing to changes tied to the company’s recent corporate restructuring.
THE APEX TIMES
The auto group is extending its collaboration with Wayve and adding Uber’s ride-hailing network as part of an effort to move toward large-scale Level 4 autonomous driving services.
THE APEX TIMES
A fresh market piece frames Johnson & Johnson as a steady income prospect, centering on the core question dividend investors ask: can the company keep paying through changing healthcare conditions?
THE APEX TIMES
Ford reported a double-digit year-over-year drop in U.S. sales in the second quarter, a move that appears driven less by weak truck demand than by product discontinuations and lower rental-related sales.
THE APEX TIMES
The telecom giant’s stock is down sharply over the past 12 months even as AT&T points to faster enterprise connectivity upgrades, postpaid subscriber gains and reaffirmed free-cash-flow guidance.
THE APEX TIMES
A new Yahoo Finance market note asks whether CVS Health’s (CVS) recent market behavior fits the playbook momentum investors typically seek, without detailing fresh company fundamentals in the material available for review.
THE APEX TIMES
A Zacks Rank upgrade to #2 (Buy) cited improved optimism around Ford Motor’s earnings outlook, a change analysts say can influence investor sentiment even before new company guidance arrives.
